Challenging fungal infections in cystic fibrosis: a case of mixed Aspergillus species infection and antifungal combination testing

References

1. Gadsby DC, Vergani P, Csanády L. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 2006; 440:477–483 [View Article] [PubMed]
   [Google Scholar]
2. Kreda SM, Davis CW, Rose MC. CFTR, mucins, and mucus obstruction in cystic fibrosis. Cold Spring Harb Perspect Med 2012; 2:a009589 [View Article] [PubMed]
   [Google Scholar]
3. Pontes L, Beraquet CAG, Arai T, Pigolli GL, Lyra L et al. Aspergillus fumigatus clinical isolates carrying CYP51A with TR34/L98H/S297T/F495I substitutions detected after four-year retrospective azole resistance screening in Brazil. Antimicrob Agents Chemother 2020; 64:02059–19 [View Article] [PubMed]
   [Google Scholar]
4. Thia LP, Balfour Lynn IM. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Paediatr Respir Rev 2009; 10:37–42 [View Article] [PubMed]
   [Google Scholar]
5. Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013; 43:850–873 [View Article] [PubMed]
   [Google Scholar]
6. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998; 27:158–163 [View Article] [PubMed]
   [Google Scholar]
7. Hodson ME, Gallagher CG, Govan JRW. A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 2002; 20:658–664 [View Article] [PubMed]
   [Google Scholar]
8. Samson RA, Visagie CM, Houbraken J, Hong S-B, Hubka V et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud Mycol 2014; 78:141–173 [View Article] [PubMed]
   [Google Scholar]
9. Bastos VR de A, Santos DW de CL, Padovan ACB, Melo ASA, Mazzolin M de A et al. Early invasive pulmonary aspergillosis in a kidney transplant recipient caused by Aspergillus lentulus: first Brazilian report. Mycopathologia 2015; 179:299–305 [View Article] [PubMed]
   [Google Scholar]
10. Yang Q, Xie J, Cai Y, Wang N, Wang Y et al. Efficacy and safety of combination antifungals as empirical, preemptive, and targeted therapies for invasive fungal infections in intensive-care units. Infect Drug Resist 2022; 15:5331–5344 [View Article] [PubMed]
    [Google Scholar]
11. Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med 2015; 162:81–89 [View Article] [PubMed]
    [Google Scholar]
12. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother 2002; 46:245–247 [View Article] [PubMed]
    [Google Scholar]
13. Clemons KV, Espiritu M, Parmar R, Stevens DA. Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrob Agents Chemother 2005; 49:4867–4875 [View Article] [PubMed]
    [Google Scholar]
14. CLSI M38-A2 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous fungi Approved Standard, 2nd. edn 2008 p 13
    [Google Scholar]
15. Denardi LB, Keller JT, de Azevedo MI, Oliveira V, Piasentin FB et al. Comparison between etest and broth microdilution methods for testing itraconazole-resistant Aspergillus fumigatus susceptibility to antifungal combinations. Mycopathologia 2018; 183:359–370 [View Article] [PubMed]
    [Google Scholar]
16. Bastos RW, Akiyama D, Dos Reis TF, Colabardini AC, Luperini RS et al. Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation. mBio 2022; 13:e0185022 [View Article] [PubMed]
    [Google Scholar]
17. Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 2018; 24 Suppl 1:e1–e38 [View Article] [PubMed]
    [Google Scholar]
18. Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med 2015; 162:81–89 [View Article] [PubMed]
    [Google Scholar]
19. Abad A, Fernández-Molina JV, Bikandi J, Ramírez A, Margareto J et al. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol 2010; 27:155–182 [View Article] [PubMed]
    [Google Scholar]
20. Blomquist A, Inghammar M, Al Shakirchi M, Ericson P, Krantz C et al. Persistent Aspergillus fumigatus infection in cystic fibrosis: impact on lung function and role of treatment of asymptomatic colonization-a registry-based case-control study. BMC Pulm Med 2022; 22:263 [View Article] [PubMed]
    [Google Scholar]